Additionally, we found that ucOCN partially suppresses ER stress and improves insulin signal transduction via PI3K/Akt/NF-κB signaling in HUVECs, implicating ucOCN as a novel therapeutic target for the treatment of the vascular complications of T2DM. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.